C-Path and Vivpro join forces to advance drug development

FHS
July 14, 2023
2:57 am

Critical Path Institute, a leading global nonprofit committed to expediting drug development through the acceleration of regulatory-endorsed solutions, today announced a newly formalized Memorandum of Understanding with Vivpro, an industry-leading provider of a revolutionary biointelligence software platform and innovative services.

ADCs breach barriers to become mainstream cancer treatment – Pharmaceutical Technology

An artist illustration of an antibody drug conjugate. Image credit: Shutterstock/MeshCube The antibody-drug conjugate (ADC) manufacturing landscape offers the potential to leverage significant opportunities for

December 17, 2024

NIH issues a policy to widen access to medical products that emerge from government-funded research

After years of prodding, the National Institutes of Health has adopted a new policy requiring companies seeking licenses to sell medical products invented with government

January 14, 2025

Valneva and Pfizer tout results for the PhII of its Lyme disease vaccine

Pfizer and Valneva are touting positive results in a Phase II trial for their Lyme disease vaccine candidate when it was administered as a booster.

September 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.